Avanos Medical Inc (NYSE:AVNS)
$ 15.2 -0.2 (-1.3%) Market Cap: 698.55 Mil Enterprise Value: 811.75 Mil PE Ratio: 44.71 PB Ratio: 0.57 GF Score: 63/100

Q3 2022 Avanos Medical Inc Earnings Call Transcript

Nov 02, 2022 / 01:00PM GMT
Release Date Price: $23.17 (+3.30%)
Operator

Good morning, and welcome to the Avanos Third Quarter 2022 Earnings Conference Call. (Operator Instructions) Please note, this event is being recorded.

I would now like to turn the conference over to Scott Galovan. Please go ahead.

Scott Galovan
Avanos Medical, Inc. - VP of Strategy & Corporate Development

Good morning, everyone, and thanks for joining us. It's my pleasure to welcome you to the Avanos 2022 third quarter earnings conference call. Presenting today will be Joe Woody, CEO; and Michael Greiner, Senior Vice President and CFO. Joe will review our quarter and current business environment as well as provide an update on our key objectives for 2022. Then Michael will discuss additional detail regarding our third quarter and review our 2022 planning assumptions. We will finish the call with Q&A. A presentation for today's call is available on the Investors section of our website, avanos.com.

As a reminder, our comments today contain forward-looking statements related to the company, our expected performance, current economic

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot